Stock Earnings
KALV Stock Sees Surge of Approximately 18.77% in Last Five Days
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals
KalVista Pharmaceuticals Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Audhya Paul K. unloaded Company’s shares for reported $24272.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24
KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24
KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24
KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or